MiniMed Group, Inc. (MMED): Cash & Equivalents

Annual figures by period end, from SEC filings.

$298.00M

As of 2026-04-24

$207.00M

As of 2026-07-31

2025-04-25 Cash & Equivalents (USD) 2026-04-24

Period ended	Cash & Equivalents	Change YoY	Source filing
2026-04-24	$298.00M	n/m	2026-06-29, Balance as of period end
2025-04-25	$11.00M	n/a	2026-06-29, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Cash & Equivalents	Change YoY
MiniMed Group, Inc. (MMED)	2026-04-24	$298.00M	n/m
West Pharmaceutical Services Inc (WST)	2025-12-31	$791.30M	+63.3%
Globus Medical Inc (GMED)	2025-12-31	$526.16M	-32.9%
Dexcom Inc (DXCM)	2025-12-31	$917.70M	+51.4%
Teleflex Inc (TFX)	2025-12-31	$378.56M	+52.7%
ResMed Inc (RMD)	2026-06-30	$1.47B	+21.5%
Integra Lifesciences Holdings Corp (IART)	2025-12-31	$235.05M	-4.6%
Merit Medical Systems Inc (MMSI)	2025-12-31	$446.40M	+18.5%
Penumbra Inc (PEN)	2025-12-31	$186.90M	-42.4%

Compare MMED, WST, GMED, DXCM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗